Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus

Cross-breed heifers given infectious bovine rhinotracheitis virus by intrauterine inoculation 1 day after natural mating with a noninfected bull were killed on postinoculation days 4 to 14. When reproductive organs were examined for gross and microscopic lesions and for virus infection, the most severe uterine lesions were found in the body and caudal portions of the uterine horns of heifers killed between postinoculation days 4 and 9. Primary pathologic features were necrosis, edema, hemorrhage, and a diffuse accumulation of mononuclear cells, mostly lymphocytes; numerous lymphocytes were in mitosis. In cranial parts of uterine horns, the only lesions observed were a few small lymphocytic foci in the endometrial lamina propria. Lesions were not seen in the oviducts. In many heifers, the ovarian corpus luteum (CL) was cystic. In a few of these heifers, the cyst had a necrotic wall that was bordered by a zone of proliferating mononuclear cells. Focal necrosis and lymphoid proliferation were common in the parenchyma of cystic and noncystic CL. Similar necrotizing lesions were sometimes present in non-CL ovarian tissue. Infectious bovine rhinotracheitis virus was most frequently isolated from the uterine body, the internal os of the cervix, and the CL. Isolations were not made from blood samples taken at the time of necropsy. Isolation of virus from the CL correlated with the detection of luteal inflammation by light microscopy, but did not correlate with the presence of cysts. There also was no correlation between cystic CL and the severity of uterine lesions.     

Recrudescence of infectious bovine rhinotracheitis virus and associated neural changes in calves treated with dexamethasone

Reactivation of infection bovine rhinotracheitis (IBR) virus in calves administered dexamethasone (DM) was studied in 2 experiments. At 2, 3, 5, 15, or 30 months after inoculation of the Los Angeles strain of IBR virus, IV injections of DM were given for 5 consecutive days to induce a recurrent infection (experiment 1). Three months after the 1st treatment, a 2nd recurrent infection was induced, using DM with the same doses as used in experiment 1. The virus was excreted from nasal secretions from the 4th to the 10th day after initial treatment with DM, and from the 6th to the 9th day after the 2nd treatment. On pathologic examination, trigeminal ganglionitis, consisting of many proliferated microglia and inflammatory cells, was observed in all DM-treated calves. Moreover, degeneration of the ganglion cells and neuronophagia were prominent features in the calves after the 2nd recurrent infection. These observations indicated that the trigeminal ganglion may be one of the latent sites of IBR virus in calves after intranasal infection and that calves can develop a recrudescent infection after DM treatment several times during their lifetime.     

Ovarian lesions induced in heifers by intravenous inoculation with modified-live infectious bovine rhinotracheitis virus on the day after breeding

Four commercially available vaccine strains of modified-live infectious bovine rhinotracheitis virus were passaged once in embryonic bovine kidney cells. Heifers were inoculated IV on the day after breeding with 5.0 ml of nondiluted cell culture fluid of each of the 4 strains. Virus was reisolated from nasal swabs and blood collected during the week after inoculation. The heifers were killed 9 to 14 days after inoculation. Mild-to-marked inflammatory and necrotic lesions were seen in the corpora lutea and ovaries of the heifers. The lesions were similar to, and almost as severe as, those resulting from the inoculation of virulent strains of infectious bovine rhinotracheitis virus. Adrenal lesions were also found in all heifers examined. Virus was reisolated from the ovaries of only 4 of the 8 heifers. However, virus was confirmed in the ovaries of all 8 heifers, using immunofluorescent or ultrastructural studies. Heifers with severe luteal damage had abnormally low plasma progesterone concentrations.     

The effect of repeated treatment with dexamethasone on the re-excretion pattern of infectious bovine rhinotracheitis virus and humoral immune response

Two cattle, free of antibody to infectious bovine rhinotracheitis virus (IBRV) were infected intranasally with IBRV, and developed specific antibody to the virus. Ten weeks later, both animals were given an intravenous course of dexamethasone (DM). Nasal excretion of physical particles of virus, as judged by electron microscopy, occurred in both animals, as early as 24 h after the first DM injection, and high levels of infectious particles appeared several days later. Neutralizing antibody titre to IBRV increased following excretion of virus. Further courses of DM given at 20 and 32 weeks following initial infection were not associated with excretion of physical, ‘non-infectious’ particles or significant changes in specific antibody titre, although on each occasion one of the two animals excreted low levels of infectious particles.     

Enhancement of infectious bovine rhinotracheitis virus replication with corticosterone

Infectious bovine rhinotrachetis virus (IBRV) progeny was increased ten to 12 fold in bovine turbinate (BT) cells treated with 10^?3 M corticosterone acetate (CCA) as demonstrated by plaque assay. Autoradiographic studies demonstrated an increased binding of ³H-corticosterone (³H-CS) in IBRV infected cells and the fractionation of labelled cells revealed 78–80% of the total hormone associated with the cytoplasmic components. Incorporation of ³H-uridine and ³H-valine precursors into cells treated with the hormone demonstrated up to 16-fold increase in RNA and protein synthesis which was inhibited by the addition of actinomycin D. The data suggest that increased rate of macromolecular synthesis in IBRV infected cells treated with the corticosteroid may result in the enhancement of virus production.     

Neural changes in recurrent infection of infectious bovine rhinotracheitis virus in calves treated with dexamethasone.

Recurrent infection by infectious bovine rhinotracheitis (IBR) virus was induced in calves by dexamethasone (DM) treatment (given 5 days) at 5 months after primary infection. The virus appeared in nasal secretions of the calves on the 4th day after initiation of DM treatment and continued until the 9th day. The calves were killed on the 1st, 3rd, 4th, 5th, 6th, 7th, 8th, 10th, and 11th days after DM treatment was started for examination by histopathologic and immunofluorescent antibody techniques. The most significant neural change was trigeminal ganglionitis with neuronophagia, which was observed from the 3rd to the 11th day. Significantly, the extent of changes in the trigeminal ganglion and medulla oblongata corresponded to the amount of DM treatment administered. The IBR virus antigen was first observed in the trigeminal ganglion cells, and thereafter, it was detected in the Schwann cells, satellite cells, neuroglia cells, and nasal mucosa until the 10th day. These observations indicate that the IBR virus is capalbe of producing a persistent infection in the trigeminal ganglion and that trigeminal ganglionitis may be a characteristic lesion for inducing the reactivation of lagent IBR virus.     

Effect of infectious bovine rhinotracheitis virus immunization on viral shedding in challenge-exposed calves treated with dexamethasone

Calves not vaccinated with infectious bovine rhinotracheitis virus (IBRV) became latently infected when challenge exposed and treated with dexamethasone (DM). Calves that shed IBRV after DM treatment were considered to be latently infected. Vaccination with a temperature-sensitive intranasal vaccine or with formalinized IBRV in Freund's complete adjuvant (IBRV-FCA) protected some, but not all, calves against latent infection--indicating a role for the immune response in preventing latent infection. That all latently infected calves were not detected after DM treatment was indicated by the fact that after a 2nd DM treatment of 3 calves treated 6 months previously and not found to shed virus, 1 of the calves was latently infected. Latently infected calves were inoculated with successive doses of IBRV-FCA and treated with DM. Nonvaccinated calves shed virus, whereas vaccinated calves similarly treated did not shed virus. Because both groups had a comparable cell-mediated immune response, as determined by blastogenic response to IBRV, but the vaccinated group had significantly higher virus-neutralizing antibody titers, a role for humoral antibody in preventing viral shedding was indicated.     

Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine

The effects of a modified-live infectious bovine rhinotracheitis virus vaccine (administered ocularly or intranasally) on experimentally induced infectious bovine keratoconjunctivitis were evaluated. The modified-live infectious bovine rhinotracheitis virus vaccine was administered to 13 male Holstein calves (intranasally in 4 and ocularly in 9; day 0). Five calves were not vaccinated and served as controls. Calves were examined daily and, starting on day 4, Moraxella bovis was administered ocularly to all 18 calves once daily for 4 days. The eyes of all calves were assigned a clinical score, and the ocular secretions were evaluated for presence of infectious bovine rhinotracheitis virus and M bovis daily until day 19. The severity of the ocular lesions was estimated by scoring the lesions clinically and by determining the protein concentration, myeloperoxidase activity, and WBC count in the tears. By day 5, conjunctivitis, chemosis, and epiphora were observed in all of the calves vaccinated ocularly. The calves vaccinated intranasally developed conjunctival plaques, but did not develop chemosis or photophobia. All of the calves developed keratitis after inoculation with M bovis. The median lesion scores were greater in both groups of vaccinated calves than in the controls. Corneal perforations developed exclusively in the vaccinated calves. The frequency of M bovis isolation from ocular secretions was significantly (P less than 0.05) greater in the vaccinated calves than in the controls. The tears from the intranasally vaccinated calves contained the highest myeloperoxidase activity and WBC count. The mean protein concentration in the tears of vaccinated calves was not significantly different from that in tears of controls.(ABSTRACT TRUNCATED AT 250 WORDS)     

Reactivation of infectious bovine rhinotracheitis virus by transport

Transport was studied as a cause of reactivation of infectious bovine rhinotracheitis virus (Bovine herpesvirus-1; BHV-1) in heifers vaccinated 2-6 months before transport, using a double dose of the thermosensitive (ts) vaccine strain (Tracherine). Eight out of 19 animals showed ts strain re-excretion over a period of 1-3 days, beginning, in 5 out of the 8 heifers, the day after transport. In 14 other heifers, only sera were examined by sero-neutralisation: only 1 out of these 14 animals showed a rise in BHV-1 neutralising antibodies. Transport can therefore be considered as a stimulus of BHV-1 reactivation.     

Clinical and immunologic responses of cattle to infectious bovine rhinotracheitis virus after infection by viral aerosol or intramuscular inoculation.

Aerosol or intramuscular exposure to infectious bovine rhinotracheitis virus elicited generally comparable levels of serum antibody in cattle, but not measurable nasal secretion antibody. Aerosol-exposed cattle developed signs of mild clinical disease, fever, and leukopenia and shed virus from their nasal passages. Cattle exposed by intra-muscular inoculation developed a brief febrile response and leukopenia but did not shed virus. After an aerosol challenge exposure, cattle in each group developed detectable nasal secretion antibodies, but no clinical signs of disease.     

Isolation of infectious bovine rhinotracheitis virus in Tanzania

Summary Infectious bovine rhinotracheitis (IBR) virus was identified for the first time in Tanzania. The virus isolations were made from cattle affected with respiratory diseases. Concurrent infection with foot-and-mouth disease was observed and enhanced the severity of the illness.

---

Sumario El virus de la rinotraqueitis infecciosa de los bovinos (I.B.R.) ha sido identificado por primera vez en Tanzania. Los aislamientos de virus fueron hechos de bovinos afectados con enfermedades respiratorias. Se observó infección concurrente con fiebre aftosa y este hecho exacerbaba la severidad de la enfermedad.

---

Résumé Ce virus a été isolé pour la première fois en Tanzanie, à partir de bétail atteint d'affections respiratoires. Cette maladie a sévi concurremment avec la fièvre aphteuse, ce qui explique sa sévérité.

     

Survival of infectious bovine rhinotracheitis virus in stored bovine semen

No loss in the titre of infectious bovine rhinotracheitis virus was found during storage in semen at –196°C for 1 year.     

新疆阿克苏地区牛传染性鼻气管炎病毒与牛副流感病毒3型感染的检测

为调查阿克苏地区是否存在牛传染性鼻气管炎病毒(IBRV)与牛副流感病毒3型(BPIV-3)的感染,从阿克苏两个规模化奶牛场采集1月龄以内可疑发病犊牛鼻液样品18份,采用双抗体夹心ELISA方法检测两种病毒的抗原,PCR方法检测牛传染性鼻气管炎病毒gD基因,RT-PCR方法检测牛副流感病毒3型的gM基因。结果表明,ELISA方法检测IBRV和BPIV-3的感染率分别为22.22%和0%;PCR方法检测IBRV的感染率为72.22%;RT-PCR检测BPIV-3的感染率为44.44%;同时患有两种病毒的检出率为22.22%。说明在阿克苏地区存在IBRV与BPIV-3的感染,且存在两种病毒的双重感染。     

Reaction of goats to infection with infectious bovine rhinotracheitis virus

Intranasal exposure of goats to infectious bovine rhinotracheitis virus resulted in mild respiratory disease and virus reisolation from nasal secretions. No disease was produced in goats exposed to the same virus by the genital or ocular routes. There was serological evidence of contact transmission of infection from infected goats to cattle. Virus recrudescence was not detected in goats treated with dexamethasone two months after virus inoculation.